Hitachi and Mitsubishi Agree to Integrate Particle Therapy System Business
Hitachi, Ltd and Mitsubishi Electric Corporation have announced that they have signed an agreement to transfer Mitsubishi Electric’s particle therapy system business to Hitachi, and integrate it to one entity. This means the design, manufacturing, sales and maintenance services relevant to Mitsubishi Electric’s particle therapy system business will be merged into Hitachi, after negotiation and approval from the relevant authorities. This is currently scheduled for April 2018.
Particle therapy is being recognised as one of the effective methods for treating cancer as the side effects are few compared with other methods and the rehabilitation is relatively fast. The number of particle therapy system facilities is increasing rapidly. There are currently 70 in operation worldwide.
Both businesses agree that the transfer to Hitachi, which is developing a wide range of healthcare businesses, is a necessary step to enhance product competitiveness through the integration of development and resources.
Graeme Moore works with Hitachi and Mitsubishi Electric Corporation on their IP portfolios.